NeuroOne Medical Technologies Corp
NMTC
View Detailed Chart
0.734USD
+0.018+2.53%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
36.58MMarket Cap
LossP/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
+2.53%
5 Days
+11.68%
1 Month
+22.16%
6 Months
+11.24%
Year to Date
-11.10%
1 Year
-3.17%
View Detailed Chart
TradingKey Stock Score of NeuroOne Medical Technologies Corp
Currency: USD Updated: 2025-12-19Key Insights
NeuroOne Medical Technologies Corp's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 89/208 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Strong Buy, with the highest price target at 2.23.In the medium term, the stock price is expected to trend down.The company has been performing strongly in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
NeuroOne Medical Technologies Corp's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
2
analysts
Strong Buy
Current Rating
2.225
Target Price
+239.69%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
NeuroOne Medical Technologies Corp Highlights
StrengthsRisks
NeuroOne Medical Technologies Corporation is a medical technology company. It is developing and commercializing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders. It may also pursue applications for other areas such as depression, mood disorders, incontinence and artificial intelligence. Its products include Evo cortical electrode technology for recording, monitoring, and stimulating brain tissue for up to 30 days; Evo sEEG electrode technology for temporary (less than 30 days) use with recording, monitoring, and stimulation equipment for the recording, monitoring, and stimulation of electrical signals at the subsurface level of the brain, and OneRF ablation system for creation of radiofrequency lesions in nervous tissue for functional neurosurgical procedures.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 62.87% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 3.45M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 3.45M.
Undervalued
The company’s latest PE is -4.43, at a low 3-year percentile range.
Institutional Buying
The latest institutional holdings are 17.15M shares, increasing 35.79% quarter-over-quarter.
Held by James Simons
Star Investor James Simons holds 692.60K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.35.
NeuroOne Medical Technologies Corp News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
NeuroOne Medical Technologies Corp Info
NeuroOne Medical Technologies Corporation is a medical technology company. It is developing and commercializing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders. It may also pursue applications for other areas such as depression, mood disorders, incontinence and artificial intelligence. Its products include Evo cortical electrode technology for recording, monitoring, and stimulating brain tissue for up to 30 days; Evo sEEG electrode technology for temporary (less than 30 days) use with recording, monitoring, and stimulation equipment for the recording, monitoring, and stimulation of electrical signals at the subsurface level of the brain, and OneRF ablation system for creation of radiofrequency lesions in nervous tissue for functional neurosurgical procedures.
Ticker SymbolNMTC
CompanyNeuroOne Medical Technologies Corp
CEORosa (David A)
Websitehttps://nmtc1.com/
FAQs
What is the current price of NeuroOne Medical Technologies Corp (NMTC)?
The current price of NeuroOne Medical Technologies Corp (NMTC) is 0.734.
What is the symbol of NeuroOne Medical Technologies Corp?
The ticker symbol of NeuroOne Medical Technologies Corp is NMTC.
What is the 52-week high of NeuroOne Medical Technologies Corp?
The 52-week high of NeuroOne Medical Technologies Corp is 1.390.
What is the 52-week low of NeuroOne Medical Technologies Corp?
The 52-week low of NeuroOne Medical Technologies Corp is 0.395.
What is the market capitalization of NeuroOne Medical Technologies Corp?
The market capitalization of NeuroOne Medical Technologies Corp is 36.58M.
What is the net income of NeuroOne Medical Technologies Corp?
The net income of NeuroOne Medical Technologies Corp is -12.32M.
Is NeuroOne Medical Technologies Corp (NMTC) currently rated as Buy, Hold, or Sell?
According to analysts, NeuroOne Medical Technologies Corp (NMTC) has an overall rating of --, with a price target of 2.225.
What is the Earnings Per Share (EPS TTM) of NeuroOne Medical Technologies Corp (NMTC)?
The Earnings Per Share (EPS TTM) of NeuroOne Medical Technologies Corp (NMTC) is -0.166.
Related Instruments
-0.24%
+0.25%
+0.87%
+1.88%
+0.22%
-0.55%
+0.53%
+0.12%
+1.35%
-0.10%
-1.23%
-0.77%
+0.10%
+0.46%
+0.46%
+0.97%
+0.59%
+0.23%
+0.45%
+1.74%
